Human Metabolome Technologies

Founded in 2007 and headquartered in Boston, Human Metabolome Technologies is a specialized service provider in the metabolomics field. The company delivers high-quality analytical data and technologies to support research into metabolic pathways, disease mechanisms, and biomarker identification. Its business model is centered on providing contract research services and analytical platforms, positioning it as a key enabler for drug discovery and diagnostic development. HMT operates as a private company, catering to a global client base across major life science markets.

Proprietary metabolomics analysis platform utilizing advanced chromatography (HPLC, GC) coupled with mass spectrometry for targeted and untargeted metabolite profiling, supported by specialized sample preparation and bioinformatics.

HMT competes with large analytical instrument companies (e.g., Thermo Fisher, Agilent) that offer services, other specialized metabolomics CROs, and academic core facilities. Differentiation is based on data quality, specialized expertise, and global service reach.